121 related articles for article (PubMed ID: 34996266)
1. A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and iRGD Peptide Fused PhaP.
Fan F; Wu X; Zhao J; Ran G; Shang S; Li M; Lu X
ACS Appl Bio Mater; 2018 Dec; 1(6):2041-2053. PubMed ID: 34996266
[TBL] [Abstract][Full Text] [Related]
2. [Development of tumor targeting PHBHHx nanoparticles by PhaP mediated immobilization of EGFR-targeting peptide].
Fan F; Ma J; Lu X; Niu T; Wu Z
Sheng Wu Gong Cheng Xue Bao; 2017 Jun; 33(6):1028-1036. PubMed ID: 28895364
[TBL] [Abstract][Full Text] [Related]
3. Poly(3-hydroxybutyrate-
Fan F; Tan D; Shang S; Wu X; Zhao J; Ran G; Lu X
Biomacromolecules; 2019 Sep; 20(9):3313-3323. PubMed ID: 31198025
[TBL] [Abstract][Full Text] [Related]
4. Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds coated with PhaP-RGD fusion protein promotes the proliferation and chondrogenic differentiation of human umbilical cord mesenchymal stem cells in vitro.
Li X; Chang H; Luo H; Wang Z; Zheng G; Lu X; He X; Chen F; Wang T; Liang J; Xu M
J Biomed Mater Res A; 2015 Mar; 103(3):1169-75. PubMed ID: 25044338
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of a tumor targeting system based on microbial synthesized PHA biopolymers and PhaP mediated functional modification.
Fan F; Wang L; Ouyang Z; Wen Y; Lu X
Appl Microbiol Biotechnol; 2018 Apr; 102(7):3229-3241. PubMed ID: 29497797
[TBL] [Abstract][Full Text] [Related]
6. [Bio-modification of polyhydroxyalkanoates and its biocompatibility with chondrocytes].
Gao T; Chang H; Fan M; Lu X; Wang Z; Zhang X; Jing X; Shi Y; Li Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Aug; 28(8):1023-9. PubMed ID: 25417320
[TBL] [Abstract][Full Text] [Related]
7. The improvement of fibroblast growth on hydrophobic biopolyesters by coating with polyhydroxyalkanoate granule binding protein PhaP fused with cell adhesion motif RGD.
Dong Y; Li P; Chen CB; Wang ZH; Ma P; Chen GQ
Biomaterials; 2010 Dec; 31(34):8921-30. PubMed ID: 20728212
[TBL] [Abstract][Full Text] [Related]
8. GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy.
Lin C; Tong F; Liu R; Xie R; Lei T; Chen Y; Yang Z; Gao H; Yu X
Acta Pharm Sin B; 2020 Dec; 10(12):2348-2361. PubMed ID: 33354506
[TBL] [Abstract][Full Text] [Related]
9. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide.
You M; Peng G; Li J; Ma P; Wang Z; Shu W; Peng S; Chen GQ
Biomaterials; 2011 Mar; 32(9):2305-13. PubMed ID: 21190731
[TBL] [Abstract][Full Text] [Related]
10. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
[TBL] [Abstract][Full Text] [Related]
11. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression of human costimulatory molecule B7-2 and construction of B7-2 immobilized polyhydroxyalkanoate nanoparticles for use as an immune activation agent.
Li MC; Liu QQ; Lu XY; Zhang YL; Wang LL
BMC Biotechnol; 2012 Jul; 12():43. PubMed ID: 22846711
[TBL] [Abstract][Full Text] [Related]
13. Engineered Aeromonas hydrophila for enhanced production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with alterable monomers composition.
Han J; Qiu YZ; Liu DC; Chen GQ
FEMS Microbiol Lett; 2004 Oct; 239(1):195-201. PubMed ID: 15451119
[TBL] [Abstract][Full Text] [Related]
14. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
[TBL] [Abstract][Full Text] [Related]
16. Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for enhanced tumor therapy.
Nie X; Zhang J; Xu Q; Liu X; Li Y; Wu Y; Chen C
J Mater Chem B; 2014 Jun; 2(21):3232-3242. PubMed ID: 32261585
[TBL] [Abstract][Full Text] [Related]
17. Microbial synthesized biodegradable PHBHHxPEG hybrid copolymer as an efficient intracellular delivery nanocarrier for kinase inhibitor.
Lu XY; Li MC; Zhu XL; Fan F; Wang LL; Ma JG
BMC Biotechnol; 2014 Jan; 14():4. PubMed ID: 24438107
[TBL] [Abstract][Full Text] [Related]
18. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
Hu C; Huang Y; Chen Y
Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
[TBL] [Abstract][Full Text] [Related]
19. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy.
Hu C; Yang X; Liu R; Ruan S; Zhou Y; Xiao W; Yu W; Yang C; Gao H
ACS Appl Mater Interfaces; 2018 Jul; 10(26):22571-22579. PubMed ID: 29878758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
